Why is Demi Moore thinner at Cannes?

Demi Moore’s Cannes look draws attention as Ozempic rumors swirl

Demi Moore, 63, appeared on the Cannes red carpet with a noticeably thinner frame, prompting renewed concern and fueling online speculation about whether weight-loss drugs—specifically Ozempic—played a role.

Moore’s appearance mattered less for any single outfit detail and more for how audiences interpreted her overall body shape compared with prior public sightings. As she walked at the 2026 Cannes Film Festival, the contrast between what fans expected and what she showed became the hook for headlines.

What the reports say

The coverage centers on two things:

• Moore’s “thinner-than-ever” look at Cannes
• The immediate emergence of rumors linking that change to Ozempic

The story is driven by public reaction rather than by any confirmed medical information. No specific confirmation about medication use is provided in the summaries available here.

Why the chatter matters

Weight changes among celebrities often become fast-moving viral narratives, especially when red-carpet appearances are widely compared across years. That can lead to speculation that overshadows the actual event Moore was attending.

Bottom line

Moore’s Cannes appearance is the trigger for the Ozempic rumor cycle, with the reporting focusing on public concern about her slimmer look. The details provided do not establish whether any medication is involved.